Innovative Gene Therapy for Rare Immune Disorders

This chapter explores a clinical trial of lentiviral gene therapy using MarniCell to treat severe leukocyte adhesion deficiency type 1 in children. While achieving remarkable survival rates, it also highlights the challenges of accessibility and cost within the gene therapy landscape.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app